SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
21-Aug-24 4:00 PM View: | Trevi Therapeutics, Inc. (TRVI) | 19-Aug-24 | Option Exercise | 16,496 | $1.43 | $23,589.30 | 7% 220.31K to 236.81K | |
21-Aug-24 4:00 PM View: | Trevi Therapeutics, Inc. (TRVI) | 19-Aug-24 | Option Sale | 16,496 | $2.96 | $48,882.60 | (7%) 236.81K to 220.31K | |
16-Aug-24 4:47 PM View: | Trevi Therapeutics, Inc. (TRVI) | 16-Aug-24 | Option Exercise | 18,660 | $1.43 | $26,683.80 | 8% 220.31K to 238.97K | |
16-Aug-24 4:47 PM View: | Trevi Therapeutics, Inc. (TRVI) | 16-Aug-24 | Option Sale | 18,660 | $2.76 | $51,440.00 | (8%) 238.97K to 220.31K | |
16-Aug-24 4:47 PM View: | Trevi Therapeutics, Inc. (TRVI) | 15-Aug-24 | Option Exercise | 12,745 | $1.43 | $18,225.30 | 6% 220.31K to 233.06K | |
16-Aug-24 4:47 PM View: | Trevi Therapeutics, Inc. (TRVI) | 15-Aug-24 | Option Sale | 12,745 | $2.79 | $35,512.70 | (5%) 233.06K to 220.31K | |
16-Aug-24 4:47 PM View: | Trevi Therapeutics, Inc. (TRVI) | 14-Aug-24 | Option Exercise | 100 | $1.43 | $143.00 | < 1% 220.31K to 220.41K | |
16-Aug-24 4:47 PM View: | Trevi Therapeutics, Inc. (TRVI) | 14-Aug-24 | Option Sale | 100 | $2.75 | $275.00 | (< 1%) 220.41K to 220.31K | |
31-May-24 4:07 PM View: | Trevi Therapeutics, Inc. (TRVI) | 29-May-24 | Option Exercise | 59,354 | $2.19 | $129,985.00 | 28% 208.45K to 267.8K | |
31-May-24 4:07 PM View: | Trevi Therapeutics, Inc. (TRVI) | 29-May-24 | Option Sale | 53,368 | $2.55 | $136,110.00 | (20%) 267.8K to 214.43K | |
13-May-19 5:00 PM View: | Trevi Therapeutics, Inc. (TRVI) | 09-May-19 | Conversion | 17,118 | -- | -- | 10% 176.61K to 193.72K | |
22-Sep-10 4:31 PM View: | Penwest Pharmaceuticals Co. (PPCO.PK) | 20-Sep-10 | Disposition (change in control) | 40,494 | -- | -- | (100%) 40.49K to 0 |